[Proceedings: Effect of triiodothyroacetic acid on the hypothalamic-pituitary-thyroid axis (author's transl)].
D000085:Acetates / Q000494:pharmacology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007457:Iodine Radioisotopes; D009230:Myxedema / Q000188:drug therapy; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects*; D013972:Thyrotropin / Q000627:therapeutic use; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology
D000085:Acetates; D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013974:Thyroxine
Action de l'acide triiodothyroacétique (TRIAC) sur l'axe hypothalamo-hypophyso-thyroïdien